Table 3.
LV geometry and function of the study population
| Non-DM (n = 143) | Non-insulin-treated DM (n = 156) | Insulin-treated DM (n = 78) | |
|---|---|---|---|
| LVEDV, mL | 259.1 (202.7, 320.5) | 267.3 (197.2, 312.9) | 282.2 (210.8, 351.5) &# |
| LVEDV index, mL/m2 | 155.1 ± 42.6 | 153.4 ± 48.8 | 173.6 ± 69.5*† |
| LVESV, mL | 189.8 (137.1, 252.6) | 193.8 (137.8, 247.1) | 211.7 (149.7, 284.7) &# |
| LVESV index, mL/m2 | 117.7 ± 41.0 | 116.2 ± 45.9 | 131.3 ± 63.7 |
| LVSV, mL | 62.9 ± 22.9 | 61.5 ± 23.8 | 71.1 ± 26.9*† |
| LVSV index, mL/m2 | 37.4 ± 10.9 | 36.1 ± 10.1 | 40.9 ± 12.7 |
| LVEF, % | 25.7 ± 8.6 | 25.2 ± 9.0 | 25.2 ± 9.2 |
| LVM, g | 127.4 ± 37.1 | 145.4 ± 39.8* | 164.2 ± 36.2*† |
| LVM index, g/m2 | 76.6 ± 20.7 | 83.5 ± 24.6* | 92.7 ± 16.8*† |
| LVEDD, mm | 64.3 ± 6.7 | 64.7 ± 6.1 | 65.2 ± 6.3 |
| LVESD, mm | 51.3 ± 4.4 | 52.0 ± 5.6 | 50.5 ± 5.9 |
| LV length, mm | 96.7 ± 12.1 | 97.3 ± 11.2 | 100.2 ± 10.8 |
| 3D-SI | 0.55 ± 0.13 | 0.57 ± 0.14 | 0.63 ± 0.15*† |
Data are presented as mean ± SD, or media (Q1–Q3).
One-way analysis of variance test: * P-value < 0.017 versus no DM cohort. † P-value < 0.017 versus DM not on insulin cohort. Kruskal-Wallis test: & P-value < 0.05 versus no DM cohort. # P-value < 0.05 versus DM not on insulin cohort
Abbreviations: LV, left ventricular; DM, diabetes mellitus; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVSV, left ventricular stroke volume; LVEF, left ventricular ejection fraction; LVM, left ventricular mass; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; 3D-SI, three-dimensional spherical index